GLJ Research Would Be 'Aggressively' Shorting Tilray (TLRY) on Today's Strength

Get Alerts TLRY Hot Sheet
Rating Summary:
4 Buy, 15 Hold, 5 Sell
Rating Trend:

Today's Overall Ratings:
Up: 12 | Down: 28 | New: 29
Join SI Premium – FREE
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
GLJ Research analysts Gordon Johnson and James Bardowski reiterated a Sell rating and $0.82 price target on Tilray (NASDAQ: TLRY) following results from the company, saying they would "aggressively" shorting the strength in the stock, saying it is a "company teetering on the edge of disaster."
The analyst commented, "Our initial take on TLRY's F2Q22 results reveal a company teetering on the edge of disaster. Specifically, the two biggest takeaways we had are that (i) reported revenue growth was egregiously misleading (as we detail below, revenue was actually down 14% y/y, not up 20% as reported), and (ii) the "surprise profit" was entirely due to non-operating items (i.e., because the stock fell 26% during the quarter, the embedded options within Tilray's warrants and convertible debt were all marked to a much lower market, resulting in a substantial non-cash, accounting gain). In conclusion, although TLRY's share price was up 15.6% following this morning's print (as of 12.15), we would aggressively be adding to short positions.
For an analyst ratings summary and ratings history on Tilray click here. For more ratings news on Tilray click here.
Shares of Tilray closed at $6.42 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) started at Overweight at Barclays on defensive characteristics
- LIC Housing Finance (LICHF:IN) PT Lowered to INR470 at JPMorgan
- Hyundai Mipo Dockyard Co Ltd (010620:KS) PT Lowered to KRW119,000 at Citi
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Short SalesRelated Entities
Gordon JohnsonSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!